Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR [7]

Bone Marrow Transplantation

Volumn 39, Issue 4, 2007, Pages 249-251

  Hamadani, M ^a   Martin, L K ^b   Benson, D M ^a   Copelan, E A ^a   Devine, S M ^a   Hofmeister, C C ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD20 ANTIGEN; CD30 ANTIGEN; CD79A ANTIGEN; FLUDARABINE; GLUCOSE; HLA B ANTIGEN; HLA DR ANTIGEN; IMATINIB; LEUKOSIALIN; MEMBRANE PROTEIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NILOTINIB; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA; VIRUS RNA;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ATAXIA; BRAIN EDEMA; CASE REPORT; CD34 SELECTION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CHIMERA; CHRONIC MYELOID LEUKEMIA; CONFUSION; CRANIOTOMY; DEATH; DIARRHEA; DONOR; DRUG DOSE REDUCTION; ENGRAFTMENT; EPSTEIN BARR VIRUS; EXTERNAL BEAM RADIOTHERAPY; FEVER; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LETTER; LIGHT CHAIN; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MALE; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REDUCED INTENSITY CONDITIONING; SEPSIS;

BIOPSY; BRAIN DISEASES; EPSTEIN-BARR VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846965585     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705575     Document Type: Letter

References (10)

1. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71: 1234-1243.
2. Gross TG, Steinbuch M, DeFor T, Shapiro RS, McGlave P, Ramsay NK et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: Risk factors, treatment and outcome. Bone Marrow Transplant 1999; 23: 251-258.
3. Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208-2216.
4. Nozzoli C, Bartolozzi B, Guidi S, Orsi A, Vannucchi AM, Leoni F et al. Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2006; 47: 167-169.
5. Nagafuji K, Eto T, Hayashi S, Oshima K, Maeda Y, Gondo H et al. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain. Bone Marrow Transplant 1998; 21: 1155-1158.
6. Pakakasama S, Eames GM, Morriss MC, Huls MH, Rooney CM, Heslop HE et al. Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes. Transplantation 2004; 78: 755-757.
7. Terasawa T, Ohashi H, Tsushita K, Utsumi M, Mukai E, Nakamura S et al. Failure to detect Epstein-Barr virus (EBV) DNA in plasma by real-time PCR in a case of EBV-associated post-transplantation lymphoproliferative disorder confined to the central nervous system. Int J Rematol 2002; 75: 416-420.
8. van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001; 98: 972-978.
9. Rooney CM, Smith CA, Ng CY, Loftin SK, Sixbey JW, Gan Y et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92: 1549-1555.
10. Snanoudj R, Durrbach A, Leblond V, Caillard S, Hurault De Ligny B, Noel C et al. Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation 2003; 76: 930-937.